Company Filing History:
Years Active: 2014-2024
Title: Naoya Okitsu: Innovator in Monoclonal Antibody Development
Introduction
Naoya Okitsu is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has advanced the understanding and application of measurement reagents in medical diagnostics.
Latest Patents
Okitsu's latest patents include innovative technologies such as a monoclonal antibody and a measurement reagent for cytokeratin 18 fragment. The first patent discloses an isolated monoclonal antibody that comprises a heavy chain and a light chain, with specific amino acid sequences outlined in SEQ ID NOs: 1, 2, and 3 for the heavy chain, and SEQ ID NOs: 4, 5, and 6 for the light chain. His second patent focuses on an anti-FDP monoclonal antibody, which is selected from three different monoclonal antibodies that exhibit varying reactivity towards FDP. This patent also includes a reagent and reagent kit for measuring FDP, along with a method for its measurement.
Career Highlights
Naoya Okitsu is currently associated with Sysmex Corporation, where he continues to push the boundaries of innovation in the field of medical diagnostics. His work has been instrumental in developing tools that enhance the accuracy and efficiency of disease detection.
Collaborations
Okitsu has collaborated with notable colleagues such as Kouji Sakaguchi and Minori Yamada. Their combined expertise has contributed to the successful development of groundbreaking technologies in the field.
Conclusion
Naoya Okitsu's contributions to the field of biotechnology, particularly in monoclonal antibody development, have made a significant impact on medical diagnostics. His innovative patents and collaborations highlight his dedication to advancing healthcare technology.